These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 8310426

  • 21. Synthesis, structure, dopamine transporter affinity, and dopamine uptake inhibition of 6-alkyl-3-benzyl-2-[(methoxycarbonyl)methyl]tropane derivatives.
    Lomenzo SA, Izenwasser S, Katz JL, Terry PD, Zhu N, Klein CL, Trudell ML.
    J Med Chem; 1997 Dec 19; 40(26):4406-14. PubMed ID: 9435910
    [Abstract] [Full Text] [Related]

  • 22. Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition.
    Lin Z, Wang W, Kopajtic T, Revay RS, Uhl GR.
    Mol Pharmacol; 1999 Aug 19; 56(2):434-47. PubMed ID: 10419565
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression.
    Lin Z, Itokawa M, Uhl GR.
    FASEB J; 2000 Apr 19; 14(5):715-28. PubMed ID: 10744628
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Proline mutations induce negative-dosage effects on uptake velocity of the dopamine transporter.
    Lin Z, Uhl GR.
    J Neurochem; 2005 Jul 19; 94(1):276-87. PubMed ID: 15953370
    [Abstract] [Full Text] [Related]

  • 32. Chemistry and pharmacology of the piperidine-based analogues of cocaine. Identification of potent DAT inhibitors lacking the tropane skeleton.
    Kozikowski AP, Araldi GL, Boja J, Meil WM, Johnson KM, Flippen-Anderson JL, George C, Saiah E.
    J Med Chem; 1998 May 21; 41(11):1962-9. PubMed ID: 9599245
    [Abstract] [Full Text] [Related]

  • 33. MPP+ toxicity and plasma membrane dopamine transporter: study using cell lines expressing the wild-type and mutant rat dopamine transporters.
    Kitayama S, Mitsuhata C, Davis S, Wang JB, Sato T, Morita K, Uhl GR, Dohi T.
    Biochim Biophys Acta; 1998 Sep 16; 1404(3):305-13. PubMed ID: 9739158
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis.
    Chen N, Vaughan RA, Reith ME.
    J Neurochem; 2001 May 16; 77(4):1116-27. PubMed ID: 11359877
    [Abstract] [Full Text] [Related]

  • 36. Substrate transport and cocaine binding of human dopamine transporter is reduced by substitution of carboxyl tail with that of bovine dopamine transporter.
    Lee SH, Cho HK, Son H, Lee YS.
    Neuroreport; 1997 Jul 28; 8(11):2591-4. PubMed ID: 9261833
    [Abstract] [Full Text] [Related]

  • 37. The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain.
    Lee FJ, Pristupa ZB, Ciliax BJ, Levey AI, Niznik HB.
    J Biol Chem; 1996 Aug 23; 271(34):20885-94. PubMed ID: 8702845
    [Abstract] [Full Text] [Related]

  • 38. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter.
    Giros B, el Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, Caron MG.
    Mol Pharmacol; 1992 Sep 23; 42(3):383-90. PubMed ID: 1406597
    [Abstract] [Full Text] [Related]

  • 39. Mechanisms of MPP(+) incorporation into cerebellar granule cells.
    González-Polo RA, Mora A, Clemente N, Sabio G, Centeno F, Soler G, Fuentes JM.
    Brain Res Bull; 2001 Sep 15; 56(2):119-23. PubMed ID: 11704348
    [Abstract] [Full Text] [Related]

  • 40. Dopamine transporter mutants, small molecules, and approaches to cocaine antagonist/dopamine transporter disinhibitor development.
    Uhl G, Lin Z, Metzger T, Dar DE.
    Methods Enzymol; 1998 Sep 15; 296():456-65. PubMed ID: 9779467
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.